|
KMID : 1039620180080050775
|
|
Korean Journal of Family Practice
2018 Volume.8 No. 5 p.775 ~ p.777
|
|
|
Utility of Serum Cytokine Fragment 21-1 on Diagnosis of Lung Cancer
|
|
You Da-Mi
Kang Dong-Su
Kim Eui-Won
Cho Doo-Wan
Park Na-Young
Son Hyo-Rim
|
|
|
Abstract
|
|
|
Background: Cytokine fragment (Cyfra) 21-1 is a segment of cytokeratin 19 present in the cytoplasm of epithelial tumor cells, and is used as a tumor marker because its serum concentration is measured as it is released into the blood upon destruction of epithelial tumor cells. The aim of this study was to compare the diagnostic efficacy of Cyfra 21-1 in the serum of patients with other lung diseases, such as lung cancer, other cancers, pneumonia, and other diseases.
Methods: From March 1, 2016 to November 30, 2016, 43 patients (15 patients with lung cancer, 5 patients with other cancers except lung cancer, 8 patients with respiratory diseases, such as pneumonia, and 15 patients who were hospitalized for other pulmonary diseases) were admitted to the hospice and family medicine departments of Gwangju Veterans Hospital and enrolled in this study. The correlation between variables, such as gender, age, history of tuberculosis, and smoking history were analyzed using crossover, linear regression, and multiple regression analyses.
Results: In the lung cancer group, the value of Cyfra 21-1 in patients with lung cancer was statistically significant with a significance of 0.000. The effects of gender, age, smoking history, and history of tuberculosis on Cyfra 21-1 were not statistically significant.
Conclusion: These results suggest that Cyfra 21-1 is a useful marker for the diagnosis of lung cancer.
|
|
|
KEYWORD
|
|
|
Lung Cancer, Pulmonary Diseases, Tuberculosis, Tumor Marker, Cytokine Fragment 21-1
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|
|